Oral semaglutide proved nearly as effective as the injectable version for treating obesity, delivering 13.7 percent average weight loss in a 64-week trial.
Reproductive healthcare advocacy organizations sound alarm about negative trends in Alabama healthcare, blaming recent restrictions on abortion and IVF.